Anaplastic atypical myeloma with extensive cutaneous involvement in a dog

J Vet Med Sci. 2012 Jan;74(1):111-5. doi: 10.1292/jvms.11-0243. Epub 2011 Aug 29.

Abstract

A 7-year-old, male, mixed breed dog was referred to the Veterinary Teaching Hospital at Kitasato University because of anorexia, lameness and multiple cutaneous lesions. Observation of bone marrow plasmacytosis, osteolytic bone lesions, serum myeloma protein and cutaneous infiltration of myeloma cells led us to a diagnosis of multiple myeloma (MM) with cutaneous involvement. Polymerase chain reaction and sequence analysis for the rearranged genes of immunoglobulin and T-cell receptor demonstrated that the neoplastic cells found in skin lesions or bone marrow are of B-lymphocyte lineage and share a common original precursor cell. The dog was treated with UW-Madison protocol or melphalan/prednisone protocol and survived 175 days. This is rare case of anaplastic MM with cutaneous involvement in dog.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Combined Chemotherapy Protocols
  • Dog Diseases / drug therapy
  • Dog Diseases / pathology*
  • Dogs
  • Fatal Outcome
  • Lomustine / therapeutic use
  • Male
  • Melphalan / administration & dosage
  • Melphalan / therapeutic use
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / pathology
  • Multiple Myeloma / veterinary*
  • Prednisolone / administration & dosage
  • Prednisolone / therapeutic use
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology
  • Skin Neoplasms / veterinary*

Substances

  • Lomustine
  • Prednisolone
  • Melphalan